Pegylated Interferon alpha-2b

News Station

Zydus successfully completes phase-2 trial of Pegylated Interferon alpha2b on COVID-19 patients

Ahmedabad-based pharma company Zydus Cadila on Thursday announced successful completion of phase-two clinical trial on COVID-19 patients with its biological…

Read More »
Back to top button